Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers

Background: Coronavirus disease (COVID-19) is a mild to severe infectious respiratory illness caused by the SARS-CoV-2 virus. Based on the numerous pieces of evidence regarding the role of opioids in immune function, viral replication, and virus-mediated pathology, we decided to assess the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Khani, Samira, Tafaroji, Javad, Yaghoubi, Mehdi, Emami Kazemabad, Mohammad Javad, Hejazi, Seyed Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076798/
https://www.ncbi.nlm.nih.gov/pubmed/37033605
http://dx.doi.org/10.3389/fphar.2023.1105176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076798/
https://www.ncbi.nlm.nih.gov/pubmed/37033605
http://dx.doi.org/10.3389/fphar.2023.1105176

Ejemplares similares